Identification, biological activity, and mechanism of the anti-ischemic quinolone analog

Chan Hee Park, Jongwon Lee, Hwi Young Jung, Min Ji Kim, Sun Ha Lim, Hyung Tae Yeo, Eung Chil Choi, Eun Jeong Yoon, Kyu Won Kim, Jong Ho Cha, Seok Ho Kim, Dong Jo Chang, Do Yeon Kwon, Funan Li, Young Ger Suh

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

The quinolone analog SQ-4004 has been identified as a potentially excellent anti-ischemic agent, which exhibited highly potent efficacy in reducing infarct volume size in vivo rat MCAO model (32.1% at 0.01 mg/kg) and potent cardioprotective effect at myocardial infarction in vivo model (26.6% at 0.01 mg/kg) while it exhibited highly reduced anti-bacterial activity. The mechanistic study revealed that the anti-ischemic activity might exert via an anti-apoptotic pathway, which implies its therapeutic uses against the ischemic cell injuries including ischemic stroke and ischemic heart disease.

Original languageEnglish
Pages (from-to)6517-6526
Number of pages10
JournalBioorganic and Medicinal Chemistry
Volume15
Issue number20
DOIs
StatePublished - 15 Oct 2007
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by a grant from the Seoul R& BD Program and the Research Institute of Medical Science, Catholic University of Daegu.

Keywords

  • Anti-apoptotic activity
  • Anti-ischemic agents
  • MCAO
  • MI
  • Quinolone analog
  • Structure-activity relationship

Fingerprint

Dive into the research topics of 'Identification, biological activity, and mechanism of the anti-ischemic quinolone analog'. Together they form a unique fingerprint.

Cite this